BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A (Q64722412)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A |
clinical trial |
Statements
Randomized, Active-controlled, Double-blind, Parallel Design Study to Evaluate the Efficacy and Safety of a Once-a-week Prophylaxis Treatment With BAY79-4980 Compared to Three Times-per-week Prophylaxis With rFVIII-FS in Previously Treated Patients With Severe Hemophilia A (English)
0 references
June 2008
0 references
April 2010
0 references
143
0 references
12 year
0 references
70 year
0 references